(RTTNews) - Enlivex Ltd. (ENLV), a biotechnology company developing therapies for inflammatory conditions associated with aging, announced positive 12-month topline results from the Phase IIa stage of its Phase I/IIa clinical trial evaluating Allocetra in patients with moderate-t